OHSU spinoff and vaccine developer acquired by San Francisco biotech company 

Portland-based TomegaVax Inc., a spinoff from Oregon Health and Science University that’s working on an HIV vaccine, was recently acquired by San Francisco-based Vir Biotechnology.

Portland Business Journal reported on the development earlier in January 2017.

You can read their full report online.

Susannah L. Bodman
Twitter: @Sciwhat
Facebook: Sciwhat.Science

(Editor’s note: One of SIP’s bloggers is now affiliated with OHSU but is not involved with any of these companies nor OHSU’s communications department. Also, the pace of posting on SIP may slow for a while, as work and other life demands have increased for both of its volunteer bloggers.)


This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s